Current Trends in Neurodegeneration: Cross Talks between Oxidative Stress, Cell Death, and Inflammation.

apoptosis cell death necrosis neurodegeneration neuroinflammation oxidative stress

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Jul 2021
Historique:
received: 19 05 2021
revised: 08 07 2021
accepted: 09 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 30 7 2021
Statut: epublish

Résumé

The human body is highly complex and comprises a variety of living cells and extracellular material, which forms tissues, organs, and organ systems. Human cells tend to turn over readily to maintain homeostasis in tissues. However, postmitotic nerve cells exceptionally have an ability to regenerate and be sustained for the entire life of an individual, to safeguard the physiological functioning of the central nervous system. For efficient functioning of the CNS, neuronal death is essential, but extreme loss of neurons diminishes the functioning of the nervous system and leads to the onset of neurodegenerative diseases. Neurodegenerative diseases range from acute to chronic severe life-altering conditions like Parkinson's disease and Alzheimer's disease. Millions of individuals worldwide are suffering from neurodegenerative disorders with little or negligible treatment available, thereby leading to a decline in their quality of life. Neuropathological studies have identified a series of factors that explain the etiology of neuronal degradation and its progression in neurodegenerative disease. The onset of neurological diseases depends on a combination of factors that causes a disruption of neurons, such as environmental, biological, physiological, and genetic factors. The current review highlights some of the major pathological factors responsible for neuronal degradation, such as oxidative stress, cell death, and neuroinflammation. All these factors have been described in detail to enhance the understanding of their mechanisms and target them for disease management.

Identifiants

pubmed: 34299052
pii: ijms22147432
doi: 10.3390/ijms22147432
pmc: PMC8306752
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Exp Neurobiol. 2015 Dec;24(4):325-40
pubmed: 26713080
Ann Neurosci. 2012 Jul;19(3):125-32
pubmed: 25205985
Asian Pac J Cancer Prev. 2020 Mar 01;21(3):593-598
pubmed: 32212783
J Alzheimers Dis. 2010;20 Suppl 2:S369-79
pubmed: 20463396
Science. 2002 Jun 14;296(5575):1991-5
pubmed: 12065827
Trends Pharmacol Sci. 2012 Oct;33(10):542-51
pubmed: 22944460
J Biol Chem. 2008 Apr 4;283(14):9089-100
pubmed: 18245082
Cell. 2016 May 5;165(4):921-35
pubmed: 27114033
Anticancer Agents Med Chem. 2012 Mar;12(3):226-38
pubmed: 22263795
Microbes Infect. 2009 Nov;11(13):1050-62
pubmed: 19733681
Neurosci Lett. 2015 Jun 2;596:33-50
pubmed: 25617478
Dis Model Mech. 2017 May 1;10(5):499-502
pubmed: 28468935
PLoS One. 2013;8(1):e55375
pubmed: 23383169
Biomed Pharmacother. 2019 Jan;109:484-492
pubmed: 30551517
J Neurochem. 2006 Jun;97(6):1690-9
pubmed: 16805777
Inflammation. 2020 Dec;43(6):2033-2047
pubmed: 32712858
Int J Mol Sci. 2020 Jun 22;21(12):
pubmed: 32580329
Neurology. 2018 Aug 7;91(6):264-270
pubmed: 29997191
Neuron. 1996 Sep;17(3):401-11
pubmed: 8816704
Neurochem Int. 2018 Nov;120:13-20
pubmed: 30016687
Antioxid Redox Signal. 2009 Mar;11(3):439-48
pubmed: 18717628
Glia. 2002 Sep;39(3):279-91
pubmed: 12203394
Exp Neurol. 2017 Dec;298(Pt A):31-41
pubmed: 28844606
Nat Rev Drug Discov. 2004 Mar;3(3):205-14
pubmed: 15031734
Semin Cell Dev Biol. 2015 Mar;39:12-9
pubmed: 25668151
Elife. 2017 Apr 25;6:
pubmed: 28440222
Cell. 2010 Mar 19;140(6):918-34
pubmed: 20303880
J Neurol Sci. 2007 Aug 15;259(1-2):46-9
pubmed: 17418237
Lancet Neurol. 2008 Jan;7(1):97-109
pubmed: 18093566
Exp Neurol. 2014 Dec;262 Pt A:8-17
pubmed: 24530639
Brain. 2017 Dec 1;140(12):3286-3300
pubmed: 29053874
Arch Neurol. 2001 Mar;58(3):411-6
pubmed: 11255444
Mitochondrion. 2010 Aug;10(5):411-8
pubmed: 20573557
Neurosci Res. 2014 Feb;79:1-12
pubmed: 24144733
Cell Death Dis. 2017 Jun 29;8(6):e2905
pubmed: 28661482
Lancet Public Health. 2020 Oct;5(10):e551-e567
pubmed: 33007212
Trends Genet. 2008 Dec;24(12):604-12
pubmed: 18992957
Nature. 2006 Oct 19;443(7113):796-802
pubmed: 17051206
Oxid Med Cell Longev. 2012;2012:428010
pubmed: 22685618
Neurochem Int. 2013 Apr;62(5):575-94
pubmed: 23266600
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Mol Cell. 2009 Mar 13;33(5):627-38
pubmed: 19285945
Biomed Pharmacother. 2004 Jan;58(1):39-46
pubmed: 14739060
Annu Rev Neurosci. 2017 Jul 25;40:189-210
pubmed: 28772101
Nature. 2006 Jun 15;441(7095):885-9
pubmed: 16625204
J Neurol Neurosurg Spine. 2016;1(1):
pubmed: 28127589
Sci Rep. 2018 Jan 12;8(1):574
pubmed: 29330409
J Neuroinflammation. 2013 Apr 01;10:43
pubmed: 23547920
Front Cell Neurosci. 2017 Jul 24;11:216
pubmed: 28790893
Free Radic Biol Med. 2002 May 1;32(9):797-803
pubmed: 11978481
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Prog Neurobiol. 2011 Dec;95(4):491-5
pubmed: 21821094
J Cell Biol. 2011 Sep 5;194(5):751-64
pubmed: 21893599
Neurosci Biobehav Rev. 1990 Summer;14(2):169-76
pubmed: 2190116
Lancet Neurol. 2014 Oct;13(10):997-1005
pubmed: 25201514
Pharmaceuticals (Basel). 2010;3(4):839-915
pubmed: 21258649
J Neuropathol Exp Neurol. 2005 Sep;64(9):816-30
pubmed: 16141792
J Res Med Sci. 2013 Jul;18(7):629
pubmed: 24516501
Alzheimers Res Ther. 2017 Mar 4;9(1):14
pubmed: 28259169
Neurochem Res. 2008 Dec;33(12):2565-74
pubmed: 18473170
Science. 2017 Jun 23;356(6344):
pubmed: 28546318
J Neurochem. 2011 Feb;116(4):588-605
pubmed: 21166675
Trends Immunol. 2016 Sep;37(9):608-620
pubmed: 27443914
Neurology. 2015 May 19;84(20):2076-85
pubmed: 25904690
J Neurosci. 2013 May 29;33(22):9498-507
pubmed: 23719816
Free Radic Biol Med. 2010 Feb 15;48(4):560-6
pubmed: 19969070
J Neurochem. 2006 Jun;97(6):1634-58
pubmed: 16805774
Curr Drug Targets. 2004 Aug;5(6):529-34
pubmed: 15270199
Neurobiol Dis. 2008 Jun;30(3):400-407
pubmed: 18440237
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4753-8
pubmed: 27071083
Neurochem Int. 2016 May;95:63-74
pubmed: 26529297
J Cell Mol Med. 2010 Mar;14(3):457-87
pubmed: 20070435
Lab Invest. 2019 Jul;99(7):958-970
pubmed: 30760863
Plant Physiol Biochem. 2010 Dec;48(12):909-30
pubmed: 20870416
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2
pubmed: 22166438
J Immunol Res. 2018 Apr 16;2018:4784268
pubmed: 29850629
Neuron. 2009 Oct 15;64(1):21-4
pubmed: 19840543
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:437-454
pubmed: 28061689
Front Neurosci. 2015 May 18;9:173
pubmed: 26041981
Trends Cell Biol. 2013 Nov;23(11):567-74
pubmed: 23968895
J Neuroimmunol. 2007 Mar;184(1-2):4-16
pubmed: 17187866
Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S3-7
pubmed: 15109580
Food Chem Toxicol. 2009 Aug;47(8):1909-13
pubmed: 19457443
Nature. 2006 Oct 19;443(7113):787-95
pubmed: 17051205
CNS Neurosci Ther. 2018 Oct;24(10):876-888
pubmed: 30058285
Nat Neurosci. 2018 Oct;21(10):1300-1309
pubmed: 30258237
Free Radic Res. 1999 Dec;31 Suppl:S39-43
pubmed: 10694039
EMBO J. 2014 Jan 7;33(1):7-22
pubmed: 24357543
Antioxid Redox Signal. 2007 Aug;9(8):1059-96
pubmed: 17571960
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Curr Pharm Des. 2007;13(18):1875-86
pubmed: 17584114
Nephron. 2018;140(2):144-147
pubmed: 29961062
Mol Med Rep. 2016 Apr;13(4):3391-6
pubmed: 26935478
Neurotoxicology. 2008 May;29(3):397-405
pubmed: 18377993
Front Pharmacol. 2020 Apr 08;11:480
pubmed: 32322215
Nature. 2016 Nov 10;539(7628):197-206
pubmed: 27830784
Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1223-33
pubmed: 16115027
Neuron. 2017 Mar 8;93(5):1015-1034
pubmed: 28279350
Nutrients. 2011 Aug;3(8):735-55
pubmed: 22254121
CNS Neurosci Ther. 2017 Jan;23(1):5-22
pubmed: 27873462
Curr Top Med Chem. 2001 Dec;1(6):529-39
pubmed: 11895129
Front Biosci (Schol Ed). 2015 Jun 01;7:189-204
pubmed: 25961695
Lancet. 1976 Dec 25;2(8000):1403
pubmed: 63862
J Clin Invest. 2017 Oct 2;127(10):3577-3587
pubmed: 28872464
Ann N Y Acad Sci. 2008 Dec;1147:70-8
pubmed: 19076432
Nat Rev Neurosci. 2003 May;4(5):365-75
pubmed: 12728264
Science. 2017 Sep 22;357(6357):1255-1261
pubmed: 28882997
J Appl Toxicol. 2016 Feb;36(2):179-88
pubmed: 26510484
J Cell Biol. 2014 Sep 1;206(5):655-70
pubmed: 25154397
J Neurol Sci. 2012 Nov 15;322(1-2):254-62
pubmed: 22669122
Antioxidants (Basel). 2020 Oct 19;9(10):
pubmed: 33086603
Science. 2016 Aug 5;353(6299):603-8
pubmed: 27493188
J Biol Chem. 2005 Apr 1;280(13):12732-41
pubmed: 15695824
J Cell Biol. 2013 Sep 2;202(5):747-63
pubmed: 23979718
Exp Neurol. 2013 Aug;246:72-83
pubmed: 22285449

Auteurs

Tapan Behl (T)

Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Rashita Makkar (R)

Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Aayush Sehgal (A)

Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Sukhbir Singh (S)

Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Neelam Sharma (N)

Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.

Gokhan Zengin (G)

Department of Biology, Faculty of Science, Selcuk University Campus, Konya 42130, Turkey.

Simona Bungau (S)

Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410073 Oradea, Romania.

Felicia Liana Andronie-Cioara (FL)

Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Mihai Alexandru Munteanu (MA)

Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Mihaela Cristina Brisc (MC)

Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Diana Uivarosan (D)

Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Ciprian Brisc (C)

Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH